Israel Q1 GDP shrinks 3.3pc annualised as Iran war weighs

Published
0

Israel’s economy contracted at an annualised rate of 3.3 per cent in the first three months of 2026, the Central Bureau of Statistics has said, as the war against Iran weighed on output, Reuters reports.

The decline was not as severe as a 4pc drop forecast in a Reuters poll of economists. The economy grew 2.9pc in 2025 and was expected to bounce back in 2026 to more than 5pc growth after a ceasefire in October ended major fighting in the two-year Gaza war.

But growth took a hit after the start of a US-Israeli conflict with Iran began on February 28, resulting in weeks of ballistic missile fire from Iran that closed schools while businesses suffered.

The Bank of Israel currently sees the economy growing 3.8pc this year, depending on whether a ceasefire forged last month with Iran holds.

In the first quarter, consumer spending fell 4.7pc, exports declined 3.7pc and government spending shed 4.8pc. Investment in fixed assets rose 12.6pc. On a per capita basis, the economy shrank 4.5pc.

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...